Filing Details

Accession Number:
0001209191-20-033491
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-02 16:13:28
Reporting Period:
2020-05-29
Accepted Time:
2020-06-02 16:13:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1347178 Vanda Pharmaceuticals Inc. VNDA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1307935 Thomas Watkins 1221 Gulf Shore Blvd N #303
Naples FL 34102
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-05-29 15,000 $7.38 45,000 No 4 M Direct
Common Stock Disposition 2020-05-29 9,677 $11.50 35,323 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Nonstatutory Stock Option (Right to Buy) Disposition 2020-05-29 15,000 $0.00 15,000 $7.38
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-06-02 No 4 M Direct
Footnotes
  1. Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire June 2, 2020 as reflected in this Form 4.
  2. The option vested in 12 equal monthly installments beginning on July 3, 2010.